Latest News and Press Releases

Cytosurge appoints Simon Egli as CEO; co-founder Pascal Behr transitions to Board to ensure strategic guidance and growth.

CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells.

CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells.

Growth in the geriatric population and the widespread prevalence of chronic and infectious disease is fueling the market demand.  Market Size – USD 69.43 Billion in 2018, Market Growth - CAGR of...

Rising need for integrated bioinformatics system in genomics and proteomics is fueling the growth of the market. Market Size – USD 6.41 Billion in 2018, Market Growth - CAGR of 13.2%, Market...